Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ulcer and gastritis.

B S Anand1, D Y Graham

  • 1Dept. of Medicine, Baylor College of Medicine and Veterans' Association Medical Center, Houston, Texas, USA.

Endoscopy
|May 1, 1999
PubMed
Summary
This summary is machine-generated.

Developments in ulcers and gastritis are increasingly focused on Helicobacter pylori. While H. pylori eradication is key, it doesn't guarantee symptom relief, necessitating post-therapy cure confirmation for duodenal ulcer disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of hepatocellular carcinoma.

Journal of cancer research and clinical oncology·2014
Same author

Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma.

Alimentary pharmacology & therapeutics·2010
Same author

Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.

Alimentary pharmacology & therapeutics·2008
Same author

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.

Journal of viral hepatitis·2006
Same author

Alcohol has no effect on hepatitis C virus replication: a meta-analysis.

Gut·2005
Same author

Drug treatment of the complications of cirrhosis in the older adult.

Drugs & aging·2001
Same journal

Correction: A novel technique for endoscopic stepwise clamping and resection of giant pedunculated colonic polyps.

Endoscopy·2026
Same journal

Feasibility and safety of an adaptive endoscopic resection algorithm guided by the muscle-retracting sign for early rectal cancer.

Endoscopy·2026
Same journal

Is ERCP losing its dominance to endoscopic ultrasound-guided biliary drainage for malignant distal biliary obstruction?

Endoscopy·2026
Same journal

Endoscopic ultrasound-guided gallbladder drainage for distal malignant biliary obstruction: It's not the tool - but knowing which one to use!

Endoscopy·2026
Same journal

Endoscopic closure of a large gastric mucosal defect using a novel endoscopic suturing device in a porcine model.

Endoscopy·2026
Same journal

Anchor clip-assisted detachable loop ligation for definitive hemostasis and closure of a high-risk bleeding gastric ulcer.

Endoscopy·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) remains central to ulcer and gastritis research.
  • A decrease in H. pylori infection rates has led to a rise in non-H. pylori ulcers.
  • Screening for H. pylori or CagA to reduce endoscopy workload has proven unsuccessful.

Purpose of the Study:

  • To review current developments in ulcers and gastritis, focusing on H. pylori.
  • To evaluate treatment efficacy for nonsteroidal anti-inflammatory drug (NSAID)-induced ulcers.
  • To examine the relationship between H. pylori, gastroesophageal reflux disease (GERD), and gastric cancer risk.

Main Methods:

  • Literature review of recent findings in ulcer and gastritis research.
  • Comparative analysis of treatment outcomes for NSAID ulcers.

Related Experiment Videos

  • Discussion of epidemiological shifts and disease risk factors.

    • Main Results:

    • Omeprazole demonstrates efficacy comparable to misoprostol for NSAID ulcer healing and prevention.
    • H2-receptor antagonists are not recommended for NSAID ulcer management.
    • H. pylori eradication may increase GERD prevalence, presenting a choice between GERD and multifocal atrophic gastritis.
    • The risk of esophagogastric junction adenocarcinoma is significantly lower than gastric cancer risk associated with CagA-positive H. pylori and atrophic gastritis.

    Conclusions:

    • Complete symptom relief post-H. pylori cure is not guaranteed for duodenal ulcer disease patients.
    • Post-therapy confirmation of H. pylori cure is becoming standard practice.
    • H. pylori management strategies must consider the balance between GERD and atrophic gastritis risks.